Skip to content

Cardinal Health CAH Other Segments — Goodwill

Other segment segments

Pharmaceutical and Specialty Solutions
$9.67B+25.0%
Cost of product sold
$0

Similar metrics at other companies

Emerald Holding logo
EEXAll Other Segments — Goodwill
$35.6M0.0%
NBT
NBTBAll Other Segments — Goodwill
$14.54M0.0%
National Healthcare logo
NHCAll Other Segments — Goodwill
$0
Mobileye Global Inc. logo
MBLYAll Other Segments — Goodwill
$111M
GATX logo
GATXOther Business Segments — Goodwill
$42M+13.5%
Ameresco logo
AMRCOther — Goodwill, net
$10.84M

Other financials

Income statement

See full
Revenue$60.9B+11.0%
Gross profit$2.5B+17.7%
Operating income$509.0M-30.3%
Net income$399.0M-21.1%
EPS (diluted)$1.69-19.5%

Balance sheet

See full
Cash & equivalents$3.9B+18.4%
Total debt$8.9B+16.1%
Total equity-$2.8B+3.9%
Total assets$56.7B+13.7%

Cash flow

See full
Operating cash flow$1.8B-37.6%
CapEx$146.0M+15.9%
Free cash flow$1.7B-40.0%

Valuation

See full
Market cap$54.98B+41.0%
Enterprise value$59.96B+38.3%
P/E35.4×+10.3×
P/S0.2×0.0×

Profitability

See full
Gross margin3.8%+0.2pp
Operating margin0.9%-0.1pp
Net margin0.6%-0.1pp
FCF margin1.7%+0.6pp

Returns & leverage

See full
Return on equity37.4%
Debt / equity4.1×
Current ratio0.9×0.0×

Where this comes from

Reported directly by Cardinal Health in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Cardinal Health’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cardinal Health's other segments — goodwill.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cardinal Health's other segments — goodwill?
Cardinal Health (CAH) reported other segments — goodwill of $1.75B in Q1 2026.
How has Cardinal Health's other segments — goodwill changed year-over-year?
Cardinal Health's other segments — goodwill increased by 49.3% year-over-year, from $1.17B to $1.75B.
What does other segments — goodwill mean?
Represents the carrying value of goodwill allocated to the 'Other' business segment, which includes non-core or miscellaneous operations outside the primary pharmaceutical and medical segments. This asset reflects the premium paid over the fair value of net identifiable assets during past acquisitions within this specific segment. It is subject to periodic impairment testing to ensure the carrying value does not exceed its recoverable amount.